Market Cap 3.93B
Revenue (ttm) 258.22M
Net Income (ttm) -28.24M
EPS (ttm) N/A
PE Ratio 41.78
Forward PE 24.94
Profit Margin -10.94%
Debt to Equity Ratio 0.44
Volume 3,060,600
Avg Vol 2,832,766
Day's Range N/A - N/A
Shares Out 236.39M
Stochastic %K 3%
Beta 0.76
Analysts Strong Sell
Price Target $26.00

Latest News on ADMA

ADMA Biologics, Inc. (ADMA) Q3 2024 Earnings Call Transcript

Nov 7, 2024, 10:12 PM EST - 2 months ago

ADMA Biologics, Inc. (ADMA) Q3 2024 Earnings Call Transcript